Lactate dehydrogenase level as a COVID-19 severity marker
Łukasz Szarpak(John Paul II Catholic University of Lublin), Miłosz Jaguszewski(Gdańsk Medical University), Kurt Ruetzler(Outcomes Research Consortium), Michał Hampel(Central Clinical Hospital), Michał Pruc, Kamil Safiejko(Medical University of Białystok), Luiza Kanczuga - Koda(Medical University of Białystok), Krzysztof J. Filipiak(Postgraduate School of Molecular Medicine)
Cited by 109
Related Papers
Tranexamic Acid in Patients Undergoing Noncardiac Surgery
|New England Journal of Medicine|2022|322
Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial
|The Lancet|2020|303